Navigation Links
University of Colorado joins forces with major research affiliate
Date:7/26/2010

AURORA (July 22, 2010) A major research company affiliated with the University of Colorado with expertise in managing clinical trials is partnering with the University of Colorado's Anschutz Medical Campus to more efficiently bring the latest stem cell discoveries from the laboratory to the patient.

CPC, formally known as the Colorado Prevention Center, officially moved into the University Physicians Incorporated building across the street from the campus on Friday.

It is the first tenant in the new building, symbolic of the emphasis researchers have placed on stem cells and their far reaching implications for the future of health care.

The company will partner with the CU School of Medicine's Charles C. Gates Center for Regenerative Medicine and Stem Cell Biology which is expected to attract research money from around the world and bring new jobs to the area.

William Hiatt, MD, president of CPC and professor of medicine at the University of Colorado, said the move will solidify "our critical relationship" with the Stem Cell Center.

"With the collaboration of the Stem Cell Center's scientists and our ability to manage future clinical trials and the School of Medicine's commitment to this combined program, our ability to advance new therapies is tremendous," he said.

CPC, the parent company of CPC Clinical Research and CPC Community Health, is a non-profit created by the Department of Medicine that has been managing clinical trials for more than 20 years. Scientists and administrators hope the partnership will speed up the transition from work in the lab to work with actual patients.

Dennis Roop, PhD, director of the Center for Regenerative Medicine and Stem Cell Biology, said the alliance could produce major breakthroughs in cancer research, treating skin diseases, regrowing damaged veins and arteries and creating a steady supply of clean, human blood.

"We could take a biopsy of a damaged cornea, grow the stem cells, transplant them to the patient and restore vision," he said. "Currently we don't have a program like that in the U.S., but this has created an opportunity to do it here."

Lilly Marks, vice-president for health affairs at the University of Colorado and executive vice-chancellor of the University of Colorado's Anschutz Medical Campus, said the move will further enhance the scope and reach of the campus.

"We want to make this the epicenter of health care throughout the Rocky Mountains and beyond," Marks said. "The stem cell research and trials that go on here will impact the entire world." Colorado State Sen. Morgan Carroll of Aurora was on hand at Friday's press conference to lend her support. "This partnership will attract research grants and new business," she said. "And it will also save lives."


'/>"/>

Contact: David Kelly
david.kelly@ucdenver.edu
303-503-7990
University of Colorado Denver
Source:Eurekalert

Related medicine news :

1. University of Virginia Health System Medical Laboratories Selects Sunquest's Specimen Collection Solution
2. Akron Institute of Herzing University Launches Its First Bachelors Degree Programs to Prepare Students for Even Greater Success in Business, Health Care and IT
3. Most pandemic plans in Ontario hospitals have not been tested: Queens University study
4. San Diego State University and BIOCOM Institute Receive $4.95 Million Grant: The BRIDGE Project, Linking Education to Employment in San Diegos Life Sciences Industry
5. Smithsonian Institution, Arizona State University announce education and research partnership
6. Untreated poor vision in elderly linked to dementia, University of Michigan study shows
7. Giarmarco, Mullins & Horton, P.C. President Joseph F. Page to Speak at University of Michigan
8. Arizona State Universitys Decision Theater offers balance to an off-kilter world
9. Forest City Announces Joint Venture with Health Care REIT for University Park Life Science Properties
10. Herzing University Online Launches Master and Bachelor of Science Degrees in Nursing
11. Nurtur Acquires ActivHealth and Wellness by Choice; Gains Exclusive Partnership with Duke University Center for Living
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2017)... ... September 22, 2017 , ... SABRE ... Scholarship Sweepstakes.,  , Molli C., a graduate student from Sonora, California, who will ... Administration at St. Thomas University in Miami, Florida, was selected from a pool ...
(Date:9/22/2017)... HOUSTON, Texas (PRWEB) , ... September 22, 2017 ... ... leading network of independent freestanding emergency rooms is celebrating the one year anniversary ... anniversary of our facility opening,” said Dr. Otinwa, Facility Medical Director of First ...
(Date:9/22/2017)... ... September 22, 2017 , ... ... products at customers’ doorstep. According to Smart Mart, customers can now order vegetable, ... offer wearable, and customers can find clothing at discounted prices. Apart from this, ...
(Date:9/21/2017)... ... September 21, 2017 , ... Process Capability ... p.m. – 3:00 p.m. ET, http://www.fdanews.com/processcapabilityindices      , Quality ... run afoul of The Quality System Regulation (§820.250), and Devicemakers find themselves staring ...
(Date:9/21/2017)... (PRWEB) , ... September 21, 2017 , ... ... in their communities, nine governmental public health departments have been awarded five-year accreditation ... decisions mean that the benefits of being served by a PHAB-accredited health ...
Breaking Medicine News(10 mins):
(Date:9/13/2017)... Sept. 13, 2017   OrthoAtlanta has been named ... Football Host Committee (AFHC) for the 2018 College Football Playoff ... 2018, at Mercedes-Benz Stadium in Atlanta, Georgia ... AFHC "I,m In" campaign, participating in many activities leading up ... ...
(Date:9/12/2017)... , Sept. 12, 2017  ValGenesis Inc., ... Solutions (VLMS), is pleased to announce the appointment ... member of its Board of Directors and Chairman ... VLMS enables life science companies to manage their ... use of paper in this process. Furthermore, ValGenesis ...
(Date:9/9/2017)...  Eli Lilly and Company (NYSE: LLY ... for lasmiditan, an investigational, oral, first-in-class molecule for the ... compared to placebo in the Phase 3 SPARTAN study. ... Congress of the International Headache Society (IHC) in ... today demonstrate lasmiditan,s potential to reduce pain and provide ...
Breaking Medicine Technology: